| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_321b10c632ca3a14bdb685ff273c4f4c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2503-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-998
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2533-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2513-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2533-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2533-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-28 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0693 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-09 |
| filingDate |
2018-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90e3ec3a67a27bf660a5831324058b6f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_862002a3194f3b5c87b99f0df23c1f52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_608fd3eed7171b4d1605702dbf3bb986
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9d04d0ee2b5b478180c40444336de72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cfd555f8fd7b9ce31ac43be718d0cef |
| publicationDate |
2019-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201938789-A |
| titleOfInvention |
In vitro diagnostic method for predicting drug efficacy |
| abstract |
The invention discloses a 3D organoid for diagnosis or analysis, wherein the 3D organoid is constructed from tumor cells. The tumor cell line in the 3D organoid comes from a cell line, from a circulating tumor cell isolated from a patient, or from a tumor tissue. The 3D organoid system is constructed using an aqueous gel material and an adhesion molecule. This aqueous gel material is a hydrogel. The adhesion molecule is ICAM-1 or galectin-3. The 3D organoid is constructed by forming a scaffold with an aqueous gel material, and then adding the mixture of tumor cells and adhesion molecules. |
| priorityDate |
2017-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |